Canary

Jane

Injective

<p>Canary Capital (<a href="https://x.com/CanaryFunds" rel="noopener noreferrer nofollow">@CanaryFunds</a>) has moved its planned staked Injective ETF to Nasdaq under the ticker INJC, according to a fourth amended registration statement filed with the U.S. Securities and Exchange Commission (SEC) on Friday. The fund, formally named the Canary Staked INJ ETF, would hold Injective's native token, <a href="https://x.com/search?q=%24INJ&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$INJ</a>, and stake at least 90% of it.</p>
<h2 id="fee-structure-and-staking-terms">Fee structure and staking terms</h2>
<p>The fund would charge a 1.10% annual fee. It would also pay 30% of its staking rewards in staking fees. An earlier amendment listed the exchange as Cboe BZX. <a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126021228/canary-s1a_092426.htm" rel="noopener noreferrer nofollow">The September 24 filing</a> states the shares would trade on Cboe BZX, while <a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/inj-s1a_102326.htm" rel="noopener noreferrer nofollow">the October 23 amendment</a> names The Nasdaq Stock Market LLC as the exchange.</p>
<p>According to the prospectus, the trust's primary objective is to provide exposure to the price of INJ, less expenses. A secondary objective is to earn additional INJ through a staking program administered by the sponsor, with rewards earned by validating transactions on the Injective proof-of-stake blockchain.</p>
<h2 id="seed-investment-and-trading-partners">Seed investment and trading partners</h2>
<p>The Injective Foundation plans to buy up to $15M of shares at the start, paid in INJ. Jane Street, Cumberland and Flowdesk are among the fund's named trading partners.</p>
<p>The fund cannot begin trading until the SEC signs off. As <a href="https://www.tokenpost.com/news/regulation/24195" rel="noopener noreferrer nofollow">TokenPost reported</a> on an earlier amendment, a registration statement does not by itself authorize an ETF to launch or begin trading.</p>
<p>Canary is not the only issuer pursuing an INJ product. <a href="https://cryptobriefing.com/injective-inj-injc-staked-etf-filing/" rel="noopener noreferrer nofollow">Crypto Briefing reported</a> that at least three INJ-related ETF applications are pending with the SEC, including proposals from 21Shares and REX-Osprey alongside Canary's.</p>
<h2 id="sources">Sources</h2>
<p><a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/inj-s1a_102326.htm" rel="noopener noreferrer nofollow">SEC: Canary Staked INJ ETF Form S-1/A (October 23, 2026)</a><br><a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/ex5-1.htm" rel="noopener noreferrer nofollow">SEC: Canary Staked INJ ETF Amendment No. 4 legal opinion</a><br><a href="https://cryptobriefing.com/injective-inj-injc-staked-etf-filing/" rel="noopener noreferrer nofollow">Crypto Briefing: Injective's INJ heads toward Wall Street with proposed INJC staking ETF</a></p>

Canary Capital’s staked Injective ETF gets its launch details

Table of Contents

BSCN

Other articles published on Oct 27, 2026

Join our free newsletter for daily crypto updates!